CEO and founder of Kode Biotech, Stephen Henry, shared his story of developing a platform technology that has been used to create a cancer immunotherapy. To a packed audience at the Hotel Coachman, Stephen described his journey, which started as a lab scientist specialising in transfusion medicine.
Stephen went on to complete two PhD’s and form the biotech company Kode Biotech. The company now has a range of Kode-based products in use around the world and a pipeline of potential new products. Stephen’s presentation was extremely enaging, demonstrating a lot of learning, a little luck and the value of networking far and wide!
Check out some photos from the event below: